Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 2,670 shares at $12.01 ($32K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $32k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |